AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇸🇳
DEFERASIROX in Senegal
9 products registered with ARP — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ASUNRA comprimé dispersible / 400 mg | 70150 | NOVARTIS PHARMA | active | — |
| ASUNRA comprimé dispersible / 100 mg | 70149 | NOVARTIS PHARMA | active | — |
| OLEPTISS comprimé / 360 mg | UNKNOWN-9d97cb53 | NOVARTIS | active | — |
| OLEPTISS comprimé / 180 mg | UNKNOWN-fc35b500 | NOVARTIS | active | — |
| OLEPTISS comprimé / 90 mg | UNKNOWN-538ef782 | NOVARTIS | active | — |
| OLEPTISS comprimé / 360 mg | UNKNOWN-f8ace388 | NOVARTIS | active | — |
| OLEPTISS comprimé / 180 mg | UNKNOWN-3098d382 | NOVARTIS | active | — |
| OLEPTISS comprimé / 90 mg | UNKNOWN-69acbee1 | NOVARTIS | active | — |
| ASUNRA comprimé dispersible / 100 mg | 7504 | NOVARTIS PHARMA | active | — |
DEFERASIROX — ARP Registration Details
ARP (Senegal) has 9 registered products containing DEFERASIROX, of which 9 are currently active. Data is sourced directly from the official ARP drug register and refreshed daily.
Track DEFERASIROX registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.